PRINZIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Prinzide, and what generic alternatives are available?
Prinzide is a drug marketed by Merck and is included in one NDA.
The generic ingredient in PRINZIDE is hydrochlorothiazide; lisinopril. There are thirty-two drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; lisinopril profile page.
Summary for PRINZIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 134 |
Clinical Trials: | 1 |
Patent Applications: | 3,848 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PRINZIDE at DailyMed |
Recent Clinical Trials for PRINZIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Centre Hospitalier Universitaire de Saint Etienne | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for PRINZIDE
US Patents and Regulatory Information for PRINZIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | PRINZIDE | hydrochlorothiazide; lisinopril | TABLET;ORAL | 019778-003 | Nov 18, 1993 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Merck | PRINZIDE | hydrochlorothiazide; lisinopril | TABLET;ORAL | 019778-001 | Feb 16, 1989 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Merck | PRINZIDE | hydrochlorothiazide; lisinopril | TABLET;ORAL | 019778-002 | Feb 16, 1989 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PRINZIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck | PRINZIDE | hydrochlorothiazide; lisinopril | TABLET;ORAL | 019778-001 | Feb 16, 1989 | ⤷ Sign Up | ⤷ Sign Up |
Merck | PRINZIDE | hydrochlorothiazide; lisinopril | TABLET;ORAL | 019778-003 | Nov 18, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Merck | PRINZIDE | hydrochlorothiazide; lisinopril | TABLET;ORAL | 019778-002 | Feb 16, 1989 | ⤷ Sign Up | ⤷ Sign Up |
Merck | PRINZIDE | hydrochlorothiazide; lisinopril | TABLET;ORAL | 019778-001 | Feb 16, 1989 | ⤷ Sign Up | ⤷ Sign Up |
Merck | PRINZIDE | hydrochlorothiazide; lisinopril | TABLET;ORAL | 019778-003 | Nov 18, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Merck | PRINZIDE | hydrochlorothiazide; lisinopril | TABLET;ORAL | 019778-002 | Feb 16, 1989 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PRINZIDE
See the table below for patents covering PRINZIDE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 523579 | ⤷ Sign Up | |
Spain | 494300 | ⤷ Sign Up | |
Greece | 72251 | ⤷ Sign Up | |
Bulgaria | 39467 | METHOD FOR PREPARING OF CARBOXYALKYL DIPEPTIDES | ⤷ Sign Up |
Bulgaria | 60339 | ⤷ Sign Up | |
Czechoslovakia | 237311 | PROCESSING OF CARBOXYALKYLDIPEPTIDE | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for PRINZIDE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0503785 | CA 2011 00026 | Denmark | ⤷ Sign Up | PRODUCT NAME: A COMBINATION OF OLMESARTAN MEDOXOMIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE; NAT. REG. NO/DATE: 46260-46269 (DK) 20110323; FIRST REG. NO/DATE: DE 79810.00.00 20101216 |
0565634 | 06C0030 | France | ⤷ Sign Up | PRODUCT NAME: EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 32075 20060623; FIRST REGISTRATION: LI - 55783 01 20020607 |
0480717 | 98C0025 | Belgium | ⤷ Sign Up | PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215 |
0443983 | C00443983/03 | Switzerland | ⤷ Sign Up | PRODUCT NAME: VALSARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE; REGISTRATION NUMBER/DATE: SWISSMEDIC 59407 16.09.2009 |
0454511 | 99C0009 | Belgium | ⤷ Sign Up | PRODUCT NAME: IRBESARTAN / HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/98/086/001 19981015 |
0502314 | C300095 | Netherlands | ⤷ Sign Up | PRODCUT NAME: TELMISARTAN, DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH VERDRAAGBAAR ZOUT, EN HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/02/213/001-010 20020419 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |